| 4001 | Cholesteryl esters in large VLDL (UKB data field 23499) | GCST90269596 | 0.84 |
| 4002 | OPHN1 levels | GCST90470126 | 0.84 |
| 4003 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T389 | ECGU000389 | 0.84 |
| 4004 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 116) | GCST90320935 | 0.84 |
| 4005 | Polyunsaturated fatty acid levels | GCST90499266 | 0.84 |
| 4006 | CHAD levels | GCST90468737 | 0.84 |
| 4007 | Beer or cider consumption (glasses per month) (UKB data field 1578, 4420) | GCST90132988 | 0.84 |
| 4008 | Sphingomyelin_34:0_[M+H]1+ levels | GCST90060241 | 0.84 |
| 4009 | MYO9B levels | GCST90469982 | 0.84 |
| 4010 | OXCT1 levels | GCST90470138 | 0.84 |
| 4011 | CIAPIN1/VEGFC ratio | GCST90314071 | 0.84 |
| 4012 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T329 | ECGU000329 | 0.84 |
| 4013 | Milk type used: Full cream (UKB data field 1418_1) | GCST90132938 | 0.84 |
| 4014 | Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levels | GCST90060318 | 0.84 |
| 4015 | Lysoalkylphosphatidylcholine (O-24:1) levels | GCST90024813 | 0.84 |
| 4016 | LBR/POLR2F ratio | GCST90315297 | 0.84 |
| 4017 | wg lh intensity-contrast lateralorbitofrontal | GCST90003803 | 0.84 |
| 4018 | Alzheimer's disease (MTAG) | GCST90449060 | 0.84 |
| 4019 | Alkenylphosphatidylethanolamine (P-20:0/18:2) levels | GCST90025056 | 0.84 |
| 4020 | Total triglycerides levels (UKB data field 23407) | GCST90269504 | 0.83 |
| 4021 | DTI TBSS MD Superior longitudinal fasciculus R | GCST90384612 | 0.83 |
| 4022 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T321 | ECGU000321 | 0.83 |
| 4023 | PDGFRA levels | GCST90470191 | 0.83 |
| 4024 | IDP dMRI TBSS L2 Genu of corpus callosum | GCST90004125 | 0.83 |
| 4025 | T1 FreeSurfer aseg Left-choroid-plexus | GCST90384156 | 0.83 |
| 4026 | ITGA5 levels | GCST90469635 | 0.83 |
| 4027 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502173 | 0.83 |
| 4028 | Hands-free device/speakerphone use with mobile phone in last 3 month | Electronic device use | UKBB00000304 | 0.83 |
| 4029 | PSMG3 levels | GCST90470362 | 0.83 |
| 4030 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T98 | ECGU000098 | 0.83 |
| 4031 | TACSTD2 levels | GCST90470798 | 0.83 |
| 4032 | Esophageal cancer | GCST90018621 | 0.83 |
| 4033 | Basal metabolic rate | Impedance measures | UKBB00000086 | 0.83 |
| 4034 | COLEC12 levels | GCST90468824 | 0.83 |
| 4035 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T92 | ECGA000092 | 0.83 |
| 4036 | Fracture of femur | FING00000552 | 0.83 |
| 4037 | Lactate levels (UKB data field 23471) | GCST90269568 | 0.83 |
| 4038 | CD69/F2R ratio | GCST90313877 | 0.83 |
| 4039 | DRG2 levels | GCST90469039 | 0.83 |
| 4040 | Concentration of small VLDL particles | GCST90499868 | 0.83 |
| 4041 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T334 | ECGU000334 | 0.83 |
| 4042 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T128 | ECGA000128 | 0.83 |
| 4043 | Prescriptions - sulfonylurea|diabetes | UKBB00000703 | 0.83 |
| 4044 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T481 | ECGU000481 | 0.83 |
| 4045 | aseg lh volume Inf-Lat-Vent | GCST90002617 | 0.82 |
| 4046 | IDP dMRI TBSS FA Anterior corona radiata L | GCST90003900 | 0.82 |
| 4047 | MANSC1 levels | GCST90469847 | 0.82 |
| 4048 | FLT3LG levels | GCST90274791 | 0.82 |
| 4049 | Breast cancer | GCST90429846 | 0.82 |
| 4050 | Total lipids in very large HDL | GCST90500423 | 0.82 |
| 4051 | Obstructed labour due to maternal pelvic abnormality | FING00000899 | 0.82 |
| 4052 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T340 | ECGU000340 | 0.82 |
| 4053 | Average diameter for LDL particles | GCST90498457 | 0.82 |
| 4054 | Cholesterol to Total Lipids in Small HDL percentage | GCST90499373 | 0.82 |
| 4055 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T151 | ECGA000151 | 0.82 |
| 4056 | IDP dMRI TBSS ISOVF Superior corona radiata R | GCST90004501 | 0.82 |
| 4057 | IDP dMRI TBSS MO Posterior limb of internal capsule R | GCST90003970 | 0.82 |
| 4058 | Mental and behavioural disorders due to use of other stimulants, including caffeine | FING00000811 | 0.82 |
| 4059 | ARHGEF5 levels | GCST90468360 | 0.82 |
| 4060 | CXCL17/LAMP3 ratio | GCST90314340 | 0.82 |
| 4061 | Free cholesterol in small VLDL | GCST90499817 | 0.82 |
| 4062 | SEC31A levels | GCST90470563 | 0.82 |
| 4063 | Triglycerides to Total Lipids in Small HDL percentage | GCST90499543 | 0.82 |
| 4064 | CRKL levels | GCST90468867 | 0.82 |
| 4065 | Monounsaturated fatty acid levels | GCST90502359 | 0.82 |
| 4066 | LAT/PLXNA4 ratio | GCST90315286 | 0.82 |
| 4067 | RELT levels | GCST90470453 | 0.82 |
| 4068 | FBLN2 levels | GCST90469193 | 0.82 |
| 4069 | IGFBP3 levels | GCST90102624 | 0.82 |
| 4070 | Operation code - anterior/posterior repair bladder/uterus | Operations | UKBB00000548 | 0.81 |
| 4071 | Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers) | FING00000752 | 0.81 |
| 4072 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T253 | ECGU000253 | 0.81 |
| 4073 | Other specified cardiac dysrhythmias (PheCode 427.3) | GCST90475975 | 0.81 |
| 4074 | IGDCC4 levels | GCST90469523 | 0.81 |
| 4075 | APOE levels | GCST90468338 | 0.81 |
| 4076 | IDP dMRI TBSS ISOVF Posterior corona radiata R | GCST90004503 | 0.81 |
| 4077 | rfMRI connectivity (ICA100 edge 1090) | GCST90005943 | 0.81 |
| 4078 | IDP dMRI ProbtrackX L2 ptr l | GCST90004292 | 0.81 |
| 4079 | PLXNA4/SRPK2 ratio | GCST90315688 | 0.81 |
| 4080 | aparc-a2009s lh area G-cingul-Post-ventral | GCST90003306 | 0.81 |
| 4081 | C36:4 Phosphatidylethanolamine levels in chronic kidney disease | GCST90257357 | 0.81 |
| 4082 | CD46/NECTIN2 ratio | GCST90313832 | 0.81 |
| 4083 | FCN2 levels | GCST90469204 | 0.81 |
| 4084 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T227 | ECGA000227 | 0.81 |
| 4085 | MVK levels | GCST90469967 | 0.81 |
| 4086 | KRT18 levels | GCST90469716 | 0.81 |
| 4087 | Principal component-derived dietary pattern 40 | GCST90133045 | 0.81 |
| 4088 | Body fat percentage (UKB data field 23099) | GCST90468160 | 0.81 |
| 4089 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T195 | ECGA000195 | 0.81 |
| 4090 | Do you currently smoke cigarettes? | GCST90476388 | 0.81 |
| 4091 | AMIGO2 levels | GCST90468292 | 0.81 |
| 4092 | N-formylmethionine levels | GCST90200343 | 0.81 |
| 4093 | Lymphoid leukemia, chronic (PheCode 204.12) | GCST90475613 | 0.81 |
| 4094 | ADGRG2 levels | GCST90468241 | 0.81 |
| 4095 | IDP dMRI ProbtrackX L3 cst l | GCST90004308 | 0.81 |
| 4096 | KLK11 levels | GCST90469697 | 0.81 |
| 4097 | aseg rh volume CerebralWhiteMatter | GCST90002632 | 0.81 |
| 4098 | IDP dMRI TBSS FA Retrolenticular part of internal capsule R | GCST90003897 | 0.81 |
| 4099 | 3,4-dihydroxybutyrate levels | GCST90199816 | 0.80 |
| 4100 | aparc-a2009s lh thickness Pole-occipital | GCST90003644 | 0.80 |
| 4101 | Left ventricular end diastole anterior wall thickness | GCST90278518 | 0.80 |
| 4102 | PGD levels | GCST90470217 | 0.80 |
| 4103 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T125 | ECGA000125 | 0.80 |
| 4104 | Hypertension (PheCode 401) | GCST90475919 | 0.80 |
| 4105 | SERPINE1/USP8 ratio | GCST90315835 | 0.80 |
| 4106 | Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000812 | 0.80 |
| 4107 | DTI TBSS FA Sagittal stratum R | GCST90384410 | 0.80 |
| 4108 | IDP dMRI TBSS MD Middle cerebellar peduncle | GCST90004027 | 0.80 |
| 4109 | Conjunctivitis | FING00000346 | 0.80 |
| 4110 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T218 | ECGU000218 | 0.80 |
| 4111 | Hippocampal right HATA volume | GCST90267969 | 0.80 |
| 4112 | Medication use (vasodilators used in cardiac diseases) | GCST90018763 | 0.80 |
| 4113 | FOLR1 levels | GCST90469259 | 0.80 |
| 4114 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T212 | ECGA000212 | 0.80 |
| 4115 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T337 | ECGA000337 | 0.80 |
| 4116 | IDP dMRI TBSS FA Anterior corona radiata R | GCST90003899 | 0.80 |
| 4117 | BLOC1S3 levels | GCST90468450 | 0.80 |
| 4118 | CRELD2 levels | GCST90468859 | 0.80 |
| 4119 | Low density lipoprotein cholesterol levels | GCST90239657 | 0.80 |
| 4120 | MGLL/PDLIM7 ratio | GCST90315438 | 0.80 |
| 4121 | Lung cancer | GCST004748 | 0.80 |
| 4122 | DNAJB1/PPME1 ratio | GCST90314510 | 0.80 |
| 4123 | Asthma mixed form (mode) (more control exclusions) | FING00000116 | 0.80 |
| 4124 | Non-cancer illness code, self-reported - high cholesterol | Medical conditions | UKBB00000516 | 0.80 |
| 4125 | Valine levels | GCST90092995 | 0.80 |
| 4126 | AmygNuclei lh volume Cortical-nucleus | GCST90002654 | 0.80 |
| 4127 | APOBR levels | GCST90468334 | 0.80 |
| 4128 | aparc-a2009s rh thickness Pole-temporal | GCST90003719 | 0.80 |
| 4129 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T113 | ECGA000113 | 0.79 |
| 4130 | ENO2/FXYD5 ratio | GCST90314659 | 0.79 |
| 4131 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T207 | ECGA000207 | 0.79 |
| 4132 | Gastric ulcer | GCST90270927 | 0.79 |
| 4133 | DTI TBSS L3 Fornix | GCST90384529 | 0.79 |
| 4134 | CD244/GP1BA ratio | GCST90313766 | 0.79 |
| 4135 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125) | GCST90320688 | 0.79 |
| 4136 | DUSP3 levels | GCST90469053 | 0.79 |
| 4137 | NUDT2 levels | GCST90470106 | 0.79 |
| 4138 | Cancer of urinary organs (incl. kidney and bladder) (PheCode 189) | GCST90475593 | 0.79 |
| 4139 | Skin sebum (glabella) | GCST90502797 | 0.79 |
| 4140 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T228 | ECGA000228 | 0.79 |
| 4141 | Other arthropathies | musculoskeletal | UKBB00000601 | 0.79 |
| 4142 | FIS1/HSPA1A ratio | GCST90314825 | 0.79 |
| 4143 | aparc-DKTatlas rh thickness lateraloccipital | GCST90003580 | 0.79 |
| 4144 | MAP2K1 levels | GCST90469851 | 0.79 |
| 4145 | total cholesterol (minimum, inv-norm transformed) | GCST90476427 | 0.79 |
| 4146 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T349 | ECGU000349 | 0.79 |
| 4147 | PDCD5 levels | GCST90470182 | 0.79 |
| 4148 | ARHGEF10 levels | GCST90468357 | 0.79 |
| 4149 | TCTN3 levels | GCST90470823 | 0.79 |
| 4150 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3) | GCST90320566 | 0.79 |
| 4151 | Primary biliary cholangitis (PBC) | FING00001211 | 0.79 |
| 4152 | CNPY4/STAT5B ratio | GCST90314155 | 0.79 |
| 4153 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T95 | ECGU000095 | 0.79 |
| 4154 | HSPB6 levels | GCST90469490 | 0.79 |
| 4155 | Concentration of chylomicrons and extremely large VLDL particles | GCST90501015 | 0.79 |
| 4156 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T496 | ECGA000496 | 0.79 |
| 4157 | Hypertension | GCST90468135 | 0.79 |
| 4158 | APOA1 levels | GCST90269537 | 0.79 |
| 4159 | BPIFB2 levels | GCST90468463 | 0.79 |
| 4160 | SH2B3 levels | GCST90470616 | 0.79 |
| 4161 | IL1RL1 levels | GCST90469574 | 0.78 |
| 4162 | Free cholesterol to total lipids ratio in large VLDL | GCST90092873 | 0.78 |
| 4163 | CNTN1/EGFR ratio | GCST90314162 | 0.78 |
| 4164 | CCL13 levels | GCST90468565 | 0.78 |
| 4165 | ATP5IF1/FIS1 ratio | GCST90313385 | 0.78 |
| 4166 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T62 | ECGU000062 | 0.78 |
| 4167 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T84 | ECGA000084 | 0.78 |
| 4168 | Free cholesterol in medium HDL | GCST90498562 | 0.78 |
| 4169 | HPSE levels | GCST90469473 | 0.78 |
| 4170 | VGF levels | GCST90471038 | 0.78 |
| 4171 | Blood cell traits latent factor 1 (white cell) | GCST90559243 | 0.78 |
| 4172 | Degree of unsaturation | GCST90502225 | 0.78 |
| 4173 | BIRC2 levels | GCST90468446 | 0.78 |
| 4174 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T490 | ECGU000490 | 0.78 |
| 4175 | Recent feelings of inadequacy | Depression | UKBB00000739 | 0.78 |
| 4176 | PMM2 levels | GCST90470270 | 0.78 |
| 4177 | MANF/PDGFB ratio | GCST90315360 | 0.78 |
| 4178 | Heart rate variability (standard deviation of normal-to-normal intervals) | GCST90281265 | 0.78 |
| 4179 | Triacylglycerol_52:5_[M+NH4]1+ levels | GCST90060506 | 0.78 |
| 4180 | NECTIN2/SPON2 ratio | GCST90315530 | 0.78 |
| 4181 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T215 | ECGU000215 | 0.78 |
| 4182 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T323 | ECGU000323 | 0.78 |
| 4183 | NUCB2 levels | GCST90470101 | 0.78 |
| 4184 | Cholesteryl Esters to Total Lipids in Medium HDL percentage | GCST90498556 | 0.78 |
| 4185 | VAV3 levels | GCST90471030 | 0.78 |
| 4186 | AGRP levels | GCST90468256 | 0.78 |
| 4187 | Total lipids in VLDL (UKB data field 23424) | GCST90269521 | 0.77 |
| 4188 | Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90500983 | 0.77 |
| 4189 | IDP T1 FAST ROIs R front operc cortex | GCST90002532 | 0.77 |
| 4190 | Subarachnoid hemorrhage | GCST90018703 | 0.77 |
| 4191 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T149 | ECGU000149 | 0.77 |
| 4192 | PEAR1/SNAP23 ratio | GCST90315643 | 0.77 |
| 4193 | TNFRSF21 levels | GCST90470912 | 0.77 |
| 4194 | Internal derangement of knee (PheCode 835) | GCST90476282 | 0.77 |
| 4195 | Triglycerides in large HDL | GCST90497888 | 0.77 |
| 4196 | Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626) | GCST90269723 | 0.77 |
| 4197 | NRSN1 levels | GCST90242062 | 0.77 |
| 4198 | Concentration of HDL particles | GCST90497406 | 0.77 |
| 4199 | Chronic obstructive pulmonary disease liability (machine learning-based score) | GCST90244098 | 0.77 |
| 4200 | IPCEF1/TBCC ratio | GCST90315188 | 0.77 |
| 4201 | Triglyceride to phosphoglyceride ratio | GCST90454483 | 0.77 |
| 4202 | IDP dMRI ProbtrackX ICVF ptr l | GCST90004394 | 0.77 |
| 4203 | Liver enzyme levels (alanine transaminase) | GCST90013405 | 0.77 |
| 4204 | EGF/MANF ratio | GCST90314609 | 0.77 |
| 4205 | CD58/LTBR ratio | GCST90313851 | 0.77 |
| 4206 | MSR1/TNFRSF21 ratio | GCST90315494 | 0.77 |
| 4207 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T261 | ECGU000261 | 0.77 |
| 4208 | MILR1 levels | GCST90469907 | 0.77 |
| 4209 | LRPAP1 levels | GCST90469800 | 0.77 |
| 4210 | IDP dMRI TBSS L3 Anterior corona radiata R | GCST90004193 | 0.76 |
| 4211 | Hip circumference | GCST90278633 | 0.76 |
| 4212 | TXLNA levels | GCST90470989 | 0.76 |
| 4213 | Degree of unsaturation | GCST90500175 | 0.76 |
| 4214 | GP6 levels | GCST90469384 | 0.76 |
| 4215 | T1 CAT volume L IX | GCST90384133 | 0.76 |
| 4216 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T386 | ECGU000386 | 0.76 |
| 4217 | Plasma propionylcarnitine (C3) levels in chronic kidney disease | GCST90265876 | 0.76 |
| 4218 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T202 | ECGA000202 | 0.76 |
| 4219 | Chronic osteomyelitis (PheCode 710.12) | GCST90476223 | 0.76 |
| 4220 | aparc-Desikan rh area TotalSurface | GCST90003107 | 0.76 |
| 4221 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T336 | ECGU000336 | 0.76 |
| 4222 | RAB2B levels | GCST90470406 | 0.76 |
| 4223 | Triglycerides in small VLDL | GCST90499915 | 0.76 |
| 4224 | KLK8/LY6D ratio | GCST90315257 | 0.76 |
| 4225 | wg lh intensity-contrast isthmuscingulate | GCST90003801 | 0.76 |
| 4226 | CA13 levels | GCST90468508 | 0.76 |
| 4227 | CC2D1A/WWP2 ratio | GCST90313668 | 0.76 |
| 4228 | Triglycerides to Total Lipids in Large VLDL percentage | GCST90498287 | 0.76 |
| 4229 | WFIKKN1 levels | GCST90471076 | 0.76 |
| 4230 | Cholesteryl Esters in Medium HDL | GCST90498538 | 0.76 |
| 4231 | HippSubfield lh volume presubiculum-head | GCST90002673 | 0.76 |
| 4232 | TCN1 levels | GCST90470819 | 0.76 |
| 4233 | FCRL2/SEMA7A ratio | GCST90314800 | 0.76 |
| 4234 | Triacylglycerol_50:2_[M+NH4]1+ levels | GCST90060473 | 0.75 |
| 4235 | REST UKBBICA NET100 1111 | GCST90386965 | 0.75 |
| 4236 | BST1 levels | GCST90468474 | 0.75 |
| 4237 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T210 | ECGA000210 | 0.75 |
| 4238 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T333 | ECGA000333 | 0.75 |
| 4239 | Mean platelet volume during the postpartum period | GCST90302233 | 0.75 |
| 4240 | NFKBIE levels | GCST90470039 | 0.75 |
| 4241 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T321 | ECGA000321 | 0.75 |
| 4242 | Free androgen index | GCST90239823 | 0.75 |
| 4243 | Shoulder lesions | Other soft tissue disorders | UKBB00000769 | 0.75 |
| 4244 | HYAL1 levels | GCST90469495 | 0.75 |
| 4245 | PPCDC/RWDD1 ratio | GCST90315704 | 0.75 |
| 4246 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T203 | ECGA000203 | 0.75 |
| 4247 | Cholesteryl Esters in VLDL | GCST90500205 | 0.75 |
| 4248 | GRAP2/TYMP ratio | GCST90314990 | 0.75 |
| 4249 | DTI TBSS MD Fornix cres+Stria terminalis L | GCST90384611 | 0.75 |
| 4250 | T1 FreeSurfer pial rh posteriorcingulate area | GCST90385844 | 0.75 |
| 4251 | HBEGF levels | GCST90012067 | 0.75 |
| 4252 | aparc-a2009s rh area G+S-subcentral | GCST90003374 | 0.75 |
| 4253 | Abdominal subcutaneous adipose tissue normalized | GCST90267348 | 0.75 |
| 4254 | NELL1 levels | GCST90242481 | 0.75 |
| 4255 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T294 | ECGU000294 | 0.75 |
| 4256 | Melanocytic naevi, other sites/unspecified | FING00000802 | 0.75 |
| 4257 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T339 | ECGU000339 | 0.75 |
| 4258 | FSTL3/LTBR ratio | GCST90314883 | 0.75 |
| 4259 | Frailty (Factor 3 - Multimorbidity) | GCST90624049 | 0.75 |
| 4260 | TRIM24 levels | GCST90470965 | 0.75 |
| 4261 | Left ventricular end diastole anterospetal wall thickness | GCST90278519 | 0.75 |
| 4262 | Concentration of very large VLDL particles | GCST90500631 | 0.75 |
| 4263 | Synonym | Fluid intelligence / reasoning | UKBB00000802 | 0.74 |
| 4264 | Cholesteryl Esters to Total Lipids in Very Large HDL percentage | GCST90500373 | 0.74 |
| 4265 | CELA3A/PLA2G1B ratio | GCST90314014 | 0.74 |
| 4266 | Sphingomyelin_36:2_[M+H]1+ levels | GCST90060263 | 0.74 |
| 4267 | Left-hemisphere limbic network to caudate white-matter structural connectivity | GCST90302737 | 0.74 |
| 4268 | 5alpha-androstan-3beta,17beta-diol disulfate levels | GCST90199835 | 0.74 |
| 4269 | CXCL6/DFFA ratio | GCST90314357 | 0.74 |
| 4270 | CSPG4 levels | GCST90468890 | 0.74 |
| 4271 | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levels | GCST90199649 | 0.74 |
| 4272 | ACOX1/VSIR ratio | GCST90313155 | 0.74 |
| 4273 | rfMRI amplitudes (ICA100 node 38) | GCST90004626 | 0.74 |
| 4274 | EHD3 levels | GCST90469089 | 0.74 |
| 4275 | aparc-a2009s lh volume G-front-inf-Opercular | GCST90002936 | 0.74 |
| 4276 | Volume of left whole amygdala | GCST90474898 | 0.74 |
| 4277 | rfMRI amplitudes (ICA25 node 14) | GCST90004581 | 0.74 |
| 4278 | EIF4G1/PLA2G4A ratio | GCST90314638 | 0.74 |
| 4279 | Emotional neglect | GCST90551846 | 0.74 |
| 4280 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T74 | ECGU000074 | 0.74 |
| 4281 | Speech-in-noise perception | GCST90044776 | 0.74 |
| 4282 | INPPL1 levels | GCST90469619 | 0.74 |
| 4283 | Stroke (MTAG) | GCST90449063 | 0.74 |
| 4284 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T320 | ECGU000320 | 0.74 |
| 4285 | Disorders of synovium and tendon | FING00000462 | 0.73 |
| 4286 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T54 | ECGA000054 | 0.73 |
| 4287 | Gouty arthropathy (PheCode 274.11) | GCST90475738 | 0.73 |
| 4288 | Pain (PheCode 338) | GCST90475836 | 0.73 |
| 4289 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90499288 | 0.73 |
| 4290 | TFPI levels | GCST90470839 | 0.73 |
| 4291 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T182 | ECGU000182 | 0.73 |
| 4292 | Diseases of arteries, arterioles and capillaries (FINNGEN) | FING00000423 | 0.73 |
| 4293 | KITLG levels | GCST90012023 | 0.73 |
| 4294 | Spondylopathies | FING00001325 | 0.73 |
| 4295 | CCN1 levels | GCST90468587 | 0.73 |
| 4296 | IDP dMRI TBSS ICVF Superior longitudinal fasciculus R | GCST90004367 | 0.73 |
| 4297 | CA13/TIA1 ratio | GCST90313567 | 0.73 |
| 4298 | Triglycerides in medium HDL | GCST90498672 | 0.73 |
| 4299 | LRRN1 levels | GCST90469806 | 0.73 |
| 4300 | Aspartate aminotransferase levels | GCST90278618 | 0.73 |
| 4301 | APOH levels | GCST90468340 | 0.73 |
| 4302 | Phospholipids in small HDL | GCST90499483 | 0.73 |
| 4303 | TRAF2/WWP2 ratio | GCST90315943 | 0.73 |
| 4304 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T59 | ECGU000059 | 0.73 |
| 4305 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T259 | ECGU000259 | 0.73 |
| 4306 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T233 | ECGU000233 | 0.73 |
| 4307 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T323 | ECGA000323 | 0.73 |
| 4308 | CD46 levels | GCST90468634 | 0.73 |
| 4309 | IDP dMRI TBSS FA Posterior thalamic radiation R | GCST90003905 | 0.73 |
| 4310 | Massiliomicrobiota abundance in stool | GCST90032470 | 0.73 |
| 4311 | Benign neoplasm of colon, rectum, anus and anal canal | Benign neoplasms | UKBB00000093 | 0.73 |
| 4312 | Concentration of medium VLDL particles | GCST90499017 | 0.73 |
| 4313 | Triglycerides in LDL | GCST90498472 | 0.73 |
| 4314 | SERPINE1/VASH1 ratio | GCST90315836 | 0.73 |
| 4315 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T226 | ECGA000226 | 0.73 |
| 4316 | Triglycerides to Total Lipids in Small HDL percentage | GCST90499530 | 0.73 |
| 4317 | CANT1/HSPB1 ratio | GCST90313617 | 0.73 |
| 4318 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T440 | ECGA000440 | 0.73 |
| 4319 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T261 | ECGA000261 | 0.73 |
| 4320 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T162 | ECGA000162 | 0.73 |
| 4321 | Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4) | GCST90475984 | 0.72 |
| 4322 | Cholesteryl Esters to Total Lipids in Large VLDL percentage | GCST90498165 | 0.72 |
| 4323 | IGF1 levels | GCST90102623 | 0.72 |
| 4324 | Ratio of triglycerides to phosphoglycerides | GCST90092983 | 0.72 |
| 4325 | Hepatomegaly (PheCode 573.3) | GCST90476092 | 0.72 |
| 4326 | SDC4/WWP2 ratio | GCST90315821 | 0.72 |
| 4327 | PEAR1/PECAM1 ratio | GCST90315641 | 0.72 |
| 4328 | TJAP1 levels | GCST90470874 | 0.72 |
| 4329 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T295 | ECGU000295 | 0.72 |
| 4330 | Treatment/medication code - bendroflumethiazide | Medications | UKBB00000843 | 0.72 |
| 4331 | Disorders of plasma-protein metabolism, not elsewhere classified | FING00000455 | 0.72 |
| 4332 | Malignant neoplasm of liver, primary (PheCode 155.1) | GCST90475569 | 0.72 |
| 4333 | Percentage of M9 (GP18) | GCST90668696 | 0.72 |
| 4334 | Volume of right cortical nucleus | GCST90475030 | 0.72 |
| 4335 | Cholesterol to Total Lipids in Large VLDL percentage | GCST90498130 | 0.72 |
| 4336 | PPME1 levels | GCST90470298 | 0.72 |
| 4337 | Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2) | GCST90044025 | 0.72 |
| 4338 | IDP dMRI ProbtrackX L1 fmi | GCST90004257 | 0.72 |
| 4339 | Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers) | FING00000754 | 0.72 |
| 4340 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T90 | ECGU000090 | 0.72 |
| 4341 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T348 | ECGU000348 | 0.72 |
| 4342 | NT5E levels | GCST90470093 | 0.72 |
| 4343 | EIF4G1/MAVS ratio | GCST90314636 | 0.72 |
| 4344 | KIFBP/TBC1D23 ratio | GCST90315250 | 0.72 |
| 4345 | FABP9 levels | GCST90469179 | 0.72 |
| 4346 | Pregnanediol-3-glucuronide levels | GCST90199917 | 0.72 |
| 4347 | Total triglycerides levels | GCST90500140 | 0.72 |
| 4348 | B4GALT1/SMOC2 ratio | GCST90313433 | 0.71 |
| 4349 | Androstenediol (3beta,17beta) monosulfate (2) levels | GCST90199871 | 0.71 |
| 4350 | Other diseases of liver | FING00001004 | 0.71 |
| 4351 | QDPR levels | GCST90470400 | 0.71 |
| 4352 | MNX1 levels | GCST90090758 | 0.71 |
| 4353 | Operation code - tonsillectomy +/- adenoids | Operations | UKBB00000567 | 0.71 |
| 4354 | ADH4/KRT18 ratio | GCST90313192 | 0.71 |
| 4355 | Arthropathy NOS | musculoskeletal | UKBB00000051 | 0.71 |
| 4356 | CDH1/CST3 ratio | GCST90313946 | 0.71 |
| 4357 | TNFRSF4/TNFRSF8 ratio | GCST90315938 | 0.71 |
| 4358 | Retinal detachment with retinal break | FING00001259 | 0.71 |
| 4359 | Plasma succinylcarnitine (C4-DC) levels in chronic kidney disease | GCST90265998 | 0.71 |
| 4360 | Triglyceride to phosphoglyceride ratio | GCST90499992 | 0.71 |
| 4361 | Acute pancreatitis | GCST90018569 | 0.71 |
| 4362 | LBR levels | GCST90469744 | 0.71 |
| 4363 | ITGB5/S100A4 ratio | GCST90315233 | 0.71 |
| 4364 | Total lipid levels in chylomicrons and extremely large VLDL | GCST90500994 | 0.71 |
| 4365 | ENDOU levels | GCST90469107 | 0.71 |
| 4366 | DNAJA2 levels | GCST90469009 | 0.71 |
| 4367 | QC T2 FLAIR-to-T1 linear alignment discrepancy | GCST90006350 | 0.71 |
| 4368 | Benign neoplasm: Rectum | FING00000196 | 0.71 |
| 4369 | T1 FreeSurfer aseg MaskVol-to-eTIV | GCST90384192 | 0.71 |
| 4370 | Types of physical activity in last 4 weeks - Heavy DIY (eg: weeding, lawn mowing, carpentry, digging) | Physical activity | UKBB00000870 | 0.71 |
| 4371 | F7/PROC ratio | GCST90314744 | 0.71 |
| 4372 | DIABLO levels | GCST90468994 | 0.71 |
| 4373 | CD48/FCRL6 ratio | GCST90313840 | 0.70 |
| 4374 | SCGN levels | GCST90470544 | 0.70 |
| 4375 | Meniscus derangement | FING00000807 | 0.70 |
| 4376 | CNTNAP4 levels | GCST90468809 | 0.70 |
| 4377 | Obesity | GCST001475 | 0.70 |
| 4378 | DOK2/SNX9 ratio | GCST90314539 | 0.70 |
| 4379 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T220 | ECGU000220 | 0.70 |
| 4380 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T333 | ECGU000333 | 0.70 |
| 4381 | Atherosclerosis, excluding cerebral and coronary sclerosis | FING00000123 | 0.70 |
| 4382 | PF4 levels | GCST90470211 | 0.70 |
| 4383 | ADAMTSL5 levels | GCST90468230 | 0.70 |
| 4384 | INPP1 levels | GCST90469616 | 0.70 |
| 4385 | Heart rate variability traits (RMSSD) | GCST004733 | 0.70 |
| 4386 | Hereditary ataxia | FING00000610 | 0.70 |
| 4387 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T149 | ECGA000149 | 0.70 |
| 4388 | DTI autoptx MD atr l tract | GCST90385222 | 0.70 |
| 4389 | Triglycerides to Total Lipids in Large LDL percentage | GCST90498092 | 0.70 |
| 4390 | IDP dMRI TBSS MD Anterior corona radiata R | GCST90004049 | 0.70 |
| 4391 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T336 | ECGA000336 | 0.70 |
| 4392 | Volume of left cortico-amygdaloid transition area | GCST90474880 | 0.70 |
| 4393 | Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501050 | 0.70 |
| 4394 | DECR1 levels | GCST90468978 | 0.70 |
| 4395 | ATXN10/CASP10 ratio | GCST90313396 | 0.70 |
| 4396 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 73) | GCST90320636 | 0.69 |
| 4397 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T264 | ECGA000264 | 0.69 |
| 4398 | Right-hemisphere dorsal attention network to pallidum white-matter structural connectivity | GCST90302809 | 0.69 |
| 4399 | Phospholipids to Total Lipids in Large VLDL percentage | GCST90498252 | 0.69 |
| 4400 | Prescriptions - beta2-agonist|bronchodilator|asthma | UKBB00000670 | 0.69 |
| 4401 | Prescriptions - albuterol | beta2-agonist,bronchodilator,asthma | UKBB00000658 | 0.69 |
| 4402 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T266 | ECGU000266 | 0.69 |
| 4403 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T335 | ECGA000335 | 0.69 |
| 4404 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502597 | 0.69 |
| 4405 | IDP dMRI ProbtrackX ICVF ptr r | GCST90004395 | 0.69 |
| 4406 | Cholesteryl esters to total lipids ratio in very large HDL | GCST90093007 | 0.69 |
| 4407 | ATP5IF1 levels | GCST90468392 | 0.69 |
| 4408 | wg lh intensity-contrast precentral | GCST90003815 | 0.69 |
| 4409 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T466 | ECGU000466 | 0.69 |
| 4410 | Other cataract | FING00000976 | 0.69 |
| 4411 | Propionylcarnitine levels | GCST90243593 | 0.69 |
| 4412 | Triacylglycerol_52:4_[M+NH4]1+ levels | GCST90060508 | 0.69 |
| 4413 | Biological Grandparent (paternal): Coronary Artery / Coronary Heart Disease | GCST90475548 | 0.69 |
| 4414 | Phospholipids to Total Lipids in Large HDL percentage | GCST90497868 | 0.69 |
| 4415 | Cholesterol levels in very large VLDL | GCST90500518 | 0.69 |
| 4416 | DTI TBSS L2 Superior fronto-occipital fasciculus R | GCST90384518 | 0.69 |
| 4417 | Treatment/medication code - paracetamol | Medications | UKBB00000853 | 0.69 |
| 4418 | Pre-eclampsia or eclampsia | FING00001201 | 0.69 |
| 4419 | Free cholesterol in large LDL | GCST90497987 | 0.69 |
| 4420 | CCL7 levels | GCST90468585 | 0.69 |
| 4421 | WARS levels | GCST90471066 | 0.68 |
| 4422 | SSNA1 levels | GCST90470750 | 0.68 |
| 4423 | CDKN1A/TMSB10 ratio | GCST90313978 | 0.68 |
| 4424 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T338 | ECGA000338 | 0.68 |
| 4425 | Heart failure | GCST009541 | 0.68 |
| 4426 | Free cholesterol in large LDL | GCST90497981 | 0.68 |
| 4427 | DBNL levels | GCST90468951 | 0.68 |
| 4428 | NFATC1/TJAP1 ratio | GCST90315540 | 0.68 |
| 4429 | CFHR5 levels | GCST90468728 | 0.68 |
| 4430 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T60 | ECGA000060 | 0.68 |
| 4431 | Ratio of polyunsaturated fatty acids to total fatty acids | GCST90092941 | 0.68 |
| 4432 | Omega-3 fatty acids to total fatty acids percentage | GCST90502088 | 0.68 |
| 4433 | Right ventricular end diastolic volume | GCST90268116 | 0.68 |
| 4434 | Glycine levels | GCST90243581 | 0.68 |
| 4435 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T448 | ECGA000448 | 0.68 |
| 4436 | Coxarthrosis, primary | FING00000363 | 0.68 |
| 4437 | MOG/SEZ6L ratio | GCST90315477 | 0.68 |
| 4438 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T330 | ECGU000330 | 0.68 |
| 4439 | NUBP1 levels | GCST90470100 | 0.68 |
| 4440 | CC2D1A/TMSB10 ratio | GCST90313667 | 0.68 |
| 4441 | AXL/MCAM ratio | GCST90313421 | 0.68 |
| 4442 | CRHBP levels | GCST90468860 | 0.68 |
| 4443 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502633 | 0.68 |
| 4444 | Concentration of very large HDL particles | GCST90500431 | 0.68 |
| 4445 | NUCB2/TRIAP1 ratio | GCST90315577 | 0.68 |
| 4446 | Fat-free mass | GCST007063 | 0.68 |
| 4447 | Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levels | GCST90060270 | 0.68 |
| 4448 | DTI TBSS L3 Cingulum hippocampus L | GCST90384561 | 0.68 |
| 4449 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T200 | ECGA000200 | 0.68 |
| 4450 | aseg lh intensity Cerebellum-Cortex | GCST90003767 | 0.68 |
| 4451 | NMI levels | GCST90470056 | 0.68 |
| 4452 | CD83/TREM2 ratio | GCST90313908 | 0.68 |
| 4453 | CD27/TNFRSF9 ratio | GCST90313778 | 0.68 |
| 4454 | SMAD5 levels | GCST90470678 | 0.68 |
| 4455 | VASP levels | GCST90471028 | 0.68 |
| 4456 | Goat cheese liking | GCST90094773 | 0.68 |
| 4457 | Alanine transaminase (ALT, minimum, inv-norm transformed) | GCST90475115 | 0.68 |
| 4458 | ENG/PEAR1 ratio | GCST90314649 | 0.68 |
| 4459 | PPP1R12A/SPARC ratio | GCST90315712 | 0.68 |
| 4460 | IDP dMRI ProbtrackX ICVF ifo r | GCST90004388 | 0.67 |
| 4461 | KYNU/SCLY ratio | GCST90315265 | 0.67 |
| 4462 | CKAP4 levels | GCST90468758 | 0.67 |
| 4463 | IDP dMRI ProbtrackX ISOVF slf r | GCST90004547 | 0.67 |
| 4464 | Red cell distribution width | GCST90025988 | 0.67 |
| 4465 | DAPK2 levels | GCST90240877 | 0.67 |
| 4466 | THY1 levels | GCST90470861 | 0.67 |
| 4467 | ThalamNuclei lh volume MDl | GCST90002724 | 0.67 |
| 4468 | FGD3 levels | GCST90469217 | 0.67 |
| 4469 | LBP levels | GCST90469743 | 0.67 |
| 4470 | IGFBP6 levels | GCST90469531 | 0.67 |
| 4471 | Valine levels | GCST90132752 | 0.67 |
| 4472 | CMC1 levels | GCST90468794 | 0.67 |
| 4473 | CD40LG/TRAF2 ratio | GCST90313828 | 0.67 |
| 4474 | SPRY2 levels | GCST90470738 | 0.67 |
| 4475 | Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers) | FING00000755 | 0.67 |
| 4476 | CCL15/CCL23 ratio | GCST90313681 | 0.67 |
| 4477 | Chronic hepatitis C infection | GCST90018585 | 0.67 |
| 4478 | Free Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500598 | 0.67 |
| 4479 | CDKN1A/PLA2G4A ratio | GCST90313974 | 0.67 |
| 4480 | ADGRE5 levels | GCST90425484 | 0.67 |
| 4481 | HAVCR1 levels | GCST90469431 | 0.67 |
| 4482 | IL6ST/LEPR ratio | GCST90315165 | 0.67 |
| 4483 | PRKG1 levels | GCST90470330 | 0.67 |
| 4484 | Diabetes type 2 with peripheral circulatory (PheCode 250.25) | GCST90475678 | 0.67 |
| 4485 | MAPK13 levels | GCST90241949 | 0.66 |
| 4486 | aparc-a2009s rh area S-postcentral | GCST90003437 | 0.66 |
| 4487 | SETMAR levels | GCST90470605 | 0.66 |
| 4488 | TXNRD1 levels | GCST90470994 | 0.66 |
| 4489 | Total Lipids in VLDL | GCST90500234 | 0.66 |
| 4490 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90500975 | 0.66 |
| 4491 | PPM1F levels | GCST90470297 | 0.66 |
| 4492 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T256 | ECGA000256 | 0.66 |
| 4493 | MAN1A2 levels | GCST90469843 | 0.66 |
| 4494 | STIP1/TMSB10 ratio | GCST90315890 | 0.66 |
| 4495 | SEZ6L2 levels | GCST90470606 | 0.66 |
| 4496 | MELTF levels | GCST90469885 | 0.66 |
| 4497 | total creatine kinase (minimum, inv-norm transformed) | GCST90476416 | 0.66 |
| 4498 | Omega-3 fatty acids to total fatty acids percentage | GCST90502082 | 0.66 |
| 4499 | IDP dMRI ProbtrackX L2 str r | GCST90004297 | 0.66 |
| 4500 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T265 | ECGU000265 | 0.66 |
| 4501 | GPLD1 levels | GCST90086890 | 0.66 |
| 4502 | AIF1 levels | GCST90468267 | 0.66 |
| 4503 | Maternal care for other conditions predominantly related to pregnancy | FING00000791 | 0.66 |
| 4504 | Docosahexaenoic acid levels | GCST90497252 | 0.66 |
| 4505 | Hypertrophic scar | FING00000642 | 0.66 |
| 4506 | Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage | GCST90501091 | 0.66 |
| 4507 | Polyunsaturated fatty acid levels | GCST90499271 | 0.66 |
| 4508 | Total concentration of lipoprotein particles | GCST90500103 | 0.66 |
| 4509 | DTI TBSS MO Middle cerebellar peduncle | GCST90384620 | 0.66 |
| 4510 | NT5C3A/PRDX5 ratio | GCST90315567 | 0.66 |
| 4511 | IDP dMRI TBSS FA Posterior thalamic radiation L | GCST90003906 | 0.66 |
| 4512 | Later onset COPD | FING00000714 | 0.66 |
| 4513 | CST6/GAL ratio | GCST90314302 | 0.66 |
| 4514 | DTI TBSS MD Posterior corona radiata R | GCST90384598 | 0.66 |
| 4515 | Excessive, frequent and irregular menstruation | FING00000524 | 0.66 |
| 4516 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502411 | 0.66 |
| 4517 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T309 | ECGU000309 | 0.66 |
| 4518 | Trihexosylcermide (d18:1/18:0) levels | GCST90024738 | 0.66 |
| 4519 | IDP T1 FAST ROIs L cerebellum VIIb | GCST90002575 | 0.65 |
| 4520 | NAGPA levels | GCST90469996 | 0.65 |
| 4521 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502385 | 0.65 |
| 4522 | Triglycerides to Total Lipids in Medium VLDL percentage | GCST90499073 | 0.65 |
| 4523 | DTI TBSS MD Superior fronto-occipital fasciculus R | GCST90384614 | 0.65 |
| 4524 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T253 | ECGA000253 | 0.65 |
| 4525 | Lysoalkylphosphatidylcholine (O-20:0) levels | GCST90025432 | 0.65 |
| 4526 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124) | GCST90320943 | 0.65 |
| 4527 | DSG2 levels | GCST90423766 | 0.65 |
| 4528 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T328 | ECGA000328 | 0.65 |
| 4529 | PLTP levels | GCST90470262 | 0.65 |
| 4530 | Facial pigmentation measurement (polar light) | GCST90002284 | 0.65 |
| 4531 | N-palmitoyl-heptadecasphingosine (d17:1/16:0) levels | GCST90200115 | 0.65 |
| 4532 | FAM171B levels | GCST90469183 | 0.65 |
| 4533 | Cholesterol in IDL | GCST90497495 | 0.65 |
| 4534 | INSR levels | GCST90241509 | 0.65 |
| 4535 | RECK levels | GCST90470445 | 0.65 |
| 4536 | CGREF1 levels | GCST90468735 | 0.65 |
| 4537 | AGR3 levels | GCST90468254 | 0.65 |
| 4538 | TARBP2/TDRKH ratio | GCST90315902 | 0.65 |
| 4539 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T163 | ECGA000163 | 0.65 |
| 4540 | CDC26 levels | GCST90468663 | 0.65 |
| 4541 | MNDA/NCF2 ratio | GCST90315472 | 0.65 |
| 4542 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T267 | ECGU000267 | 0.65 |
| 4543 | Artrosis, including avohilmo | FING00000112 | 0.65 |
| 4544 | Caries in Clefts patients | FING00000256 | 0.65 |
| 4545 | ASAH1 levels | GCST90468373 | 0.65 |
| 4546 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320684 | 0.65 |
| 4547 | BRAP levels | GCST90468464 | 0.65 |
| 4548 | Cryptic phenotype that captures alpha-1-antitrypsin deficiency severity | GCST90101825 | 0.65 |
| 4549 | RBKS levels | GCST90470433 | 0.65 |
| 4550 | Phospholipids to total lipids in small LDL percentage (UKB data field 23624) | GCST90269721 | 0.65 |
| 4551 | Triglycerides | GCST002216 | 0.65 |
| 4552 | Breathing problems responsible for leaving job | Employment history | UKBB00000112 | 0.65 |
| 4553 | Erectile dysfunction [ED] (PheCode 605) | GCST90476161 | 0.65 |
| 4554 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T159 | ECGA000159 | 0.65 |
| 4555 | MICB or MICA levels | GCST90469905 | 0.65 |
| 4556 | BACH1/NFATC1 ratio | GCST90313444 | 0.65 |
| 4557 | SNAP23/TBL1X ratio | GCST90315856 | 0.65 |
| 4558 | ISM1 levels | GCST90469630 | 0.65 |
| 4559 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T494 | ECGA000494 | 0.65 |
| 4560 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T76 | ECGA000076 | 0.65 |
| 4561 | DTI TBSS L3 Sagittal stratum L | GCST90384555 | 0.65 |
| 4562 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T188 | ECGU000188 | 0.64 |
| 4563 | HSPA1A levels | GCST90469487 | 0.64 |
| 4564 | SH3BP1 levels | GCST90470619 | 0.64 |
| 4565 | REST UKBBICA NODEamps25 0016 | GCST90385499 | 0.64 |
| 4566 | SUSD2 levels | GCST90470787 | 0.64 |
| 4567 | EDAR levels | GCST90425556 | 0.64 |
| 4568 | ZBTB16 levels | GCST90471095 | 0.64 |
| 4569 | Seronegative rheumatoid arthritis | FING00001296 | 0.64 |
| 4570 | IDP dMRI TBSS ICVF Posterior thalamic radiation L | GCST90004356 | 0.64 |
| 4571 | PPP3R1 levels | GCST90470307 | 0.64 |
| 4572 | RTN4IP1 levels | GCST90470507 | 0.64 |
| 4573 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T194 | ECGA000194 | 0.64 |
| 4574 | Sphingomyelin_38:1_[M+H]1+ levels | GCST90060306 | 0.64 |
| 4575 | CHRDL1 levels | GCST90468750 | 0.64 |
| 4576 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T61 | ECGA000061 | 0.64 |
| 4577 | GRPEL1 levels | GCST90469405 | 0.64 |
| 4578 | ALDH1A1 levels | GCST90468280 | 0.64 |
| 4579 | Biological Father: High blood pressure | GCST90475243 | 0.64 |
| 4580 | Bone marrow fat fraction of thoracic vertebra 10 | GCST90652382 | 0.64 |
| 4581 | Ceramide (d16:1/22:0) levels | GCST90024026 | 0.64 |
| 4582 | aseg lh volume CerebralWhiteMatter | GCST90002615 | 0.64 |
| 4583 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T292 | ECGA000292 | 0.64 |
| 4584 | CWC15 levels | GCST90468920 | 0.64 |
| 4585 | aparc-Desikan rh volume supramarginal | GCST90002831 | 0.64 |
| 4586 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T252 | ECGA000252 | 0.64 |
| 4587 | SPINK2 levels | GCST90470722 | 0.64 |
| 4588 | Urine N-acetylglutamate levels in chronic kidney disease | GCST90265569 | 0.64 |
| 4589 | TIMM10 levels | GCST90470867 | 0.64 |
| 4590 | Other disorders of eye and adnexa | FING00001025 | 0.63 |
| 4591 | Eye problems/disorders - Glaucoma | Eyesight | UKBB00000231 | 0.63 |
| 4592 | Triglycerides to Total Lipids in Small LDL percentage | GCST90499726 | 0.63 |
| 4593 | Cholesterol in medium HDL (UKB data field 23568) | GCST90269665 | 0.63 |
| 4594 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502596 | 0.63 |
| 4595 | DTI TBSS MD Sagittal stratum R | GCST90384602 | 0.63 |
| 4596 | Insomnia complaints | GCST006487 | 0.63 |
| 4597 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T334 | ECGA000334 | 0.63 |
| 4598 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T344 | ECGU000344 | 0.63 |
| 4599 | ThalamNuclei lh volume L-Sg | GCST90002716 | 0.63 |
| 4600 | VEGFD levels | GCST90471037 | 0.63 |
| 4601 | HGF/MMP8 ratio | GCST90315055 | 0.63 |
| 4602 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T262 | ECGU000262 | 0.63 |
| 4603 | Cancer of liver and intrahepatic bile duct (PheCode 155) | GCST90475568 | 0.63 |
| 4604 | FST levels | GCST90012080 | 0.63 |
| 4605 | LILRA2 levels | GCST90469771 | 0.63 |
| 4606 | Phospholipids to Total Lipids in Very Large VLDL percentage | GCST90500665 | 0.63 |
| 4607 | Sleep disorders | neurological | UKBB00000776 | 0.63 |
| 4608 | Osteoarthritis; localized | musculoskeletal | UKBB00000595 | 0.63 |
| 4609 | IDP dMRI TBSS ICVF Body of corpus callosum | GCST90004330 | 0.63 |
| 4610 | Triacylglycerol_45:4_[M+NH4]1+ levels | GCST90060333 | 0.63 |
| 4611 | TRIM58 levels | GCST90470969 | 0.63 |
| 4612 | Concentration of large VLDL particles | GCST90498223 | 0.63 |
| 4613 | Illnesses of mother: Alzheimer's disease/dementia (UKB data field 20110_10) | GCST90042678 | 0.63 |
| 4614 | Triglycerides in medium VLDL | GCST90499064 | 0.63 |
| 4615 | ADAM12 levels | GCST90468216 | 0.63 |
| 4616 | SNAP25 levels | GCST90470691 | 0.63 |
| 4617 | Leucine levels (UKB data field 23466) | GCST90269563 | 0.63 |
| 4618 | SLA2 levels | GCST90470648 | 0.63 |
| 4619 | Milk type used - Full cream | Diet | UKBB00000468 | 0.63 |
| 4620 | CA1 levels | GCST90468510 | 0.63 |
| 4621 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T388 | ECGU000388 | 0.63 |
| 4622 | Urine taurodeoxycholic acid 3-sulfate levels in chronic kidney disease | GCST90266045 | 0.63 |
| 4623 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T123 | ECGA000123 | 0.63 |
| 4624 | FLT1/TFPI2 ratio | GCST90314856 | 0.63 |
| 4625 | Benign neoplasm of colon | neoplasms | UKBB00000092 | 0.63 |
| 4626 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T351 | ECGU000351 | 0.63 |
| 4627 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 83) | GCST90320902 | 0.63 |
| 4628 | ENTPD5 levels | GCST90469121 | 0.63 |
| 4629 | Cholesterol levels in very large VLDL | GCST90500517 | 0.63 |
| 4630 | DARS1 levels | GCST90468947 | 0.62 |
| 4631 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T489 | ECGU000489 | 0.62 |
| 4632 | LCN2/PRTN3 ratio | GCST90315307 | 0.62 |
| 4633 | DBNL/PDGFB ratio | GCST90314422 | 0.62 |
| 4634 | Cholesterol esters in very large HDL | GCST90500354 | 0.62 |
| 4635 | Fractured bone site(s) - Wrist | Medical conditions | UKBB00000257 | 0.62 |
| 4636 | Triglycerides to total lipids ratio in large VLDL | GCST90092879 | 0.62 |
| 4637 | Other disorders of circulatory system | circulatory system | UKBB00000607 | 0.62 |
| 4638 | ADAMTS16 levels | GCST90468224 | 0.62 |
| 4639 | potassium (minimum, inv-norm transformed) | GCST90476310 | 0.62 |
| 4640 | Saturated fatty acids to total fatty acids percentage | GCST90502684 | 0.62 |
| 4641 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T122 | ECGU000122 | 0.62 |
| 4642 | Human herpes virus 7 U14 antibody levels | GCST90006909 | 0.62 |
| 4643 | Illnesses of mother - Diabetes | Family history | UKBB00000347 | 0.62 |
| 4644 | TACC3 levels | GCST90470797 | 0.62 |
| 4645 | Linoleic acid levels | GCST90502311 | 0.62 |
| 4646 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T345 | ECGU000345 | 0.62 |
| 4647 | aparc-Desikan rh thickness lateraloccipital | GCST90003489 | 0.62 |
| 4648 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T73 | ECGA000073 | 0.62 |
| 4649 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T254 | ECGA000254 | 0.62 |
| 4650 | RNF5 levels | GCST90470488 | 0.62 |
| 4651 | Omega-3 fatty acid levels | GCST90502436 | 0.62 |
| 4652 | FAM3C/NECTIN2 ratio | GCST90314781 | 0.62 |
| 4653 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T146 | ECGA000146 | 0.62 |
| 4654 | IDP dMRI TBSS FA Middle cerebellar peduncle | GCST90003877 | 0.62 |
| 4655 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T234 | ECGU000234 | 0.62 |
| 4656 | NTRK3 levels | GCST90470098 | 0.62 |
| 4657 | Left-hemisphere visual network to thalamus white-matter structural connectivity | GCST90302662 | 0.62 |
| 4658 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T465 | ECGU000465 | 0.62 |
| 4659 | Other and unspecified anaemias | FING00000925 | 0.62 |
| 4660 | GRSF1 levels | GCST90469407 | 0.62 |
| 4661 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T201 | ECGA000201 | 0.62 |
| 4662 | GDI2 levels | GCST90088004 | 0.62 |
| 4663 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502570 | 0.62 |
| 4664 | Triglycerides to Total Lipids in Very Large VLDL percentage | GCST90500695 | 0.62 |
| 4665 | Phospholipids to total lipids ratio in very large VLDL | GCST90093025 | 0.62 |
| 4666 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T300 | ECGA000300 | 0.62 |
| 4667 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T189 | ECGU000189 | 0.62 |
| 4668 | Free cholesterol in very large HDL | GCST90500380 | 0.61 |
| 4669 | aparc-DKTatlas rh thickness pericalcarine | GCST90003590 | 0.61 |
| 4670 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26) | GCST90320589 | 0.61 |
| 4671 | aparc-a2009s rh area G-oc-temp-lat-fusifor | GCST90003391 | 0.61 |
| 4672 | Cerebrospinal fluid beta-hydroxyisovaleroylcarnitine levels | GCST90318013 | 0.61 |
| 4673 | Triglycerides in large LDL | GCST90498076 | 0.61 |
| 4674 | MCAM/NCAM1 ratio | GCST90315408 | 0.61 |
| 4675 | CD40/TIMP3 ratio | GCST90313829 | 0.61 |
| 4676 | Omega-6 fatty acids to total fatty acids percentage | GCST90502129 | 0.61 |
| 4677 | IDP dMRI TBSS MD Posterior limb of internal capsule R | GCST90004045 | 0.61 |
| 4678 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T241 | ECGA000241 | 0.61 |
| 4679 | Free Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500398 | 0.61 |
| 4680 | IDP dMRI TBSS L2 Uncinate fasciculus R | GCST90004167 | 0.61 |
| 4681 | Linoleic acid to total fatty acids percentage | GCST90502337 | 0.61 |
| 4682 | Primary gonarthrosis, bilateral | FING00001213 | 0.61 |
| 4683 | Triglycerides in medium LDL | GCST90498864 | 0.61 |
| 4684 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T477 | ECGU000477 | 0.61 |
| 4685 | ACAN levels | GCST90468196 | 0.61 |
| 4686 | Duodenal ulcer | FING00000481 | 0.61 |
| 4687 | ACYP2 levels | GCST90240187 | 0.61 |
| 4688 | aparc-a2009s lh area S-central | GCST90003341 | 0.61 |
| 4689 | CHRDL2 levels | GCST90468751 | 0.61 |
| 4690 | Radial peak diastolic strain rate | GCST90019014 | 0.61 |
| 4691 | FOXO3/SH2B3 ratio | GCST90314881 | 0.61 |
| 4692 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T347 | ECGU000347 | 0.61 |
| 4693 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T499 | ECGU000499 | 0.61 |
| 4694 | aparc-Desikan rh area supramarginal | GCST90003137 | 0.61 |
| 4695 | Concentration of medium HDL particles (UKB data field 23565) | GCST90269662 | 0.61 |
| 4696 | X-24947 levels | GCST90200651 | 0.61 |
| 4697 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T82 | ECGA000082 | 0.61 |
| 4698 | ENG/TNFSF10 ratio | GCST90314651 | 0.61 |
| 4699 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T145 | ECGA000145 | 0.61 |
| 4700 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T148 | ECGU000148 | 0.61 |
| 4701 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T251 | ECGA000251 | 0.61 |
| 4702 | GSTA1 levels | GCST90469411 | 0.61 |
| 4703 | Left ventricular end diastolic mass | GCST90268123 | 0.61 |
| 4704 | L3HYPDH levels | GCST90469724 | 0.61 |
| 4705 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T339 | ECGA000339 | 0.60 |
| 4706 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T67 | ECGA000067 | 0.60 |
| 4707 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T260 | ECGA000260 | 0.60 |
| 4708 | Smoking status - Current | Smoking | UKBB00000779 | 0.60 |
| 4709 | wg rh intensity-contrast superiorparietal | GCST90003855 | 0.60 |
| 4710 | IGSF3 levels | GCST90469539 | 0.60 |
| 4711 | KLK6/MOG ratio | GCST90315255 | 0.60 |
| 4712 | ALCAM levels | GCST90468279 | 0.60 |
| 4713 | S100A12 levels | GCST90470513 | 0.60 |
| 4714 | EFEMP1/IL18BP ratio | GCST90314596 | 0.60 |
| 4715 | TBCC levels | GCST90470814 | 0.60 |
| 4716 | IDP T1 FAST ROIs R cerebellum IX | GCST90002586 | 0.60 |
| 4717 | Chronic heart failure | GCST90018586 | 0.60 |
| 4718 | CD55/CHI3L1 ratio | GCST90313845 | 0.60 |
| 4719 | CELA3A/CPA1 ratio | GCST90314009 | 0.60 |
| 4720 | ZFYVE19 levels | GCST90471098 | 0.60 |
| 4721 | Septal defects | FING00001293 | 0.60 |
| 4722 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T264 | ECGU000264 | 0.60 |
| 4723 | Multi-trait sex score | GCST90270116 | 0.60 |
| 4724 | SNCG levels | GCST90470695 | 0.60 |
| 4725 | Volume of right cortical nucleus | GCST90474919 | 0.60 |
| 4726 | Cholesteryl Esters in Small VLDL | GCST90499786 | 0.60 |
| 4727 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T99 | ECGU000099 | 0.60 |
| 4728 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T103 | ECGA000103 | 0.60 |
| 4729 | SKAP2 levels | GCST90470646 | 0.60 |
| 4730 | FLT4 levels | GCST90469252 | 0.60 |
| 4731 | Sleep disorders | Episodic and paroxysmal disorders | UKBB00000775 | 0.59 |
| 4732 | HARS1 levels | GCST90469430 | 0.59 |
| 4733 | Other heart diseases | FING00001057 | 0.59 |
| 4734 | TNFAIP8L2 levels | GCST90470897 | 0.59 |
| 4735 | Total triglycerides levels | GCST90500126 | 0.59 |
| 4736 | Cancer of bladder (PheCode 189.2) | GCST90475598 | 0.59 |
| 4737 | SDCCAG8 levels | GCST90470560 | 0.59 |
| 4738 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T249 | ECGA000249 | 0.59 |
| 4739 | Gastric ulcer | GCST90018631 | 0.59 |
| 4740 | STIP1 levels | GCST90470764 | 0.59 |
| 4741 | Total Lipids in VLDL | GCST90500236 | 0.59 |
| 4742 | IDP dMRI TBSS ISOVF Corticospinal tract R | GCST90004483 | 0.59 |
| 4743 | CD99L2/CPM ratio | GCST90313925 | 0.59 |
| 4744 | DTI TBSS L2 Superior longitudinal fasciculus L | GCST90384517 | 0.59 |
| 4745 | IDP dMRI TBSS ICVF Uncinate fasciculus R | GCST90004371 | 0.59 |
| 4746 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T248 | ECGU000248 | 0.59 |
| 4747 | HSPG2/PTGDS ratio | GCST90315092 | 0.59 |
| 4748 | HEXIM1/IKBKG ratio | GCST90315045 | 0.59 |
| 4749 | Treatment/medication code - quinine | Medications | UKBB00000855 | 0.59 |
| 4750 | IDP dMRI ProbtrackX MD str r | GCST90004243 | 0.59 |
| 4751 | Cholesteryl Esters to Total Lipids in Very Large VLDL percentage | GCST90500565 | 0.59 |
| 4752 | IDP T1 FAST ROIs L cerebellum V | GCST90002564 | 0.59 |
| 4753 | Docosahexaenoic acid levels | GCST90502258 | 0.59 |
| 4754 | APEX1 levels | GCST90468329 | 0.59 |
| 4755 | Right-hemisphere salience/ventral attention network to putamen white-matter structural connectivity | GCST90302819 | 0.59 |
| 4756 | AGRP levels | GCST90012063 | 0.59 |
| 4757 | PLAU levels | GCST90470252 | 0.59 |
| 4758 | VEGFC levels | GCST90471036 | 0.59 |
| 4759 | CD302 levels | GCST90468624 | 0.59 |
| 4760 | Iritis | GCST90018651 | 0.59 |
| 4761 | Free cholesterol in very large VLDL | GCST90500575 | 0.59 |
| 4762 | Lysoalkylphosphatidylcholine (O-22:0) levels | GCST90024195 | 0.59 |
| 4763 | RRM2 levels | GCST90470501 | 0.59 |
| 4764 | TNFSF13 levels | GCST90470921 | 0.58 |
| 4765 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T250 | ECGA000250 | 0.58 |
| 4766 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502155 | 0.58 |
| 4767 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T116 | ECGU000116 | 0.58 |
| 4768 | HTRA2/SNAP29 ratio | GCST90315098 | 0.58 |
| 4769 | CD69/SNAP29 ratio | GCST90313887 | 0.58 |
| 4770 | Wears glasses or contact lenses (UKB data field 2207) | GCST90042875 | 0.58 |
| 4771 | CCL17 levels | GCST90468569 | 0.58 |
| 4772 | FKBP7 levels | GCST90469245 | 0.58 |
| 4773 | Phospholipids to total lipids ratio in very small VLDL | GCST90093037 | 0.58 |
| 4774 | ICD10 O14: Pre-eclampsia | GCST90454233 | 0.58 |
| 4775 | SEPHS1 levels | GCST90242740 | 0.58 |
| 4776 | BA-exvivo rh volume BA4a | GCST90002853 | 0.58 |
| 4777 | IDP dMRI TBSS FA External capsule R | GCST90003909 | 0.58 |
| 4778 | Wears glasses or contact lenses | Eyesight | UKBB00000907 | 0.58 |
| 4779 | Seborrheic keratosis (PheCode 702.2) | GCST90476206 | 0.58 |
| 4780 | Other circulatory problem | GCST90475217 | 0.58 |
| 4781 | AMBP/ASGR1 ratio | GCST90313251 | 0.58 |
| 4782 | NRP2 levels | GCST90470086 | 0.58 |
| 4783 | Total lipids in medium VLDL | GCST90498994 | 0.58 |
| 4784 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T383 | ECGA000383 | 0.58 |
| 4785 | LBR/MAD1L1 ratio | GCST90315295 | 0.58 |
| 4786 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T91 | ECGA000091 | 0.58 |
| 4787 | T1 FreeSurfer aseg Left-Putamen | GCST90384145 | 0.58 |
| 4788 | Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers) | FING00000866 | 0.58 |
| 4789 | JAM2/THBD ratio | GCST90315239 | 0.58 |
| 4790 | PLA2G15/SMPDL3A ratio | GCST90315663 | 0.58 |
| 4791 | Lung volume | GCST90016668 | 0.58 |
| 4792 | LRRC37A2 levels | GCST90469802 | 0.58 |
| 4793 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90499287 | 0.58 |
| 4794 | Phospholipid levels in very large HDL | GCST90093012 | 0.58 |
| 4795 | PENK levels | GCST90470208 | 0.58 |
| 4796 | IDP T1 FAST ROIs L cerebellum crus II | GCST90002572 | 0.58 |
| 4797 | Diacylglycerol_32:2_[M+H-H2O]1+ levels | GCST90060168 | 0.58 |
| 4798 | Brain glioblastoma, excluding all cancers (controls excluding all cancers) | FING00000225 | 0.58 |
| 4799 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472 | ECGU000472 | 0.57 |
| 4800 | Triglycerides to Total Lipids in Large HDL percentage | GCST90497906 | 0.57 |
| 4801 | Rheumatoid arthritis (PheCode 714.1) | GCST90476230 | 0.57 |
| 4802 | MCFD2/VSIR ratio | GCST90315411 | 0.57 |
| 4803 | Guanidinoacetate levels | GCST90200384 | 0.57 |
| 4804 | DSCAM levels | GCST90469041 | 0.57 |
| 4805 | VSIG4 levels | GCST90471052 | 0.57 |
| 4806 | B4GAT1 levels | GCST90468413 | 0.57 |
| 4807 | BECN1 levels | GCST90468438 | 0.57 |
| 4808 | CLEC1B/ITGB5 ratio | GCST90314094 | 0.57 |
| 4809 | Cholesteryl Esters in Medium HDL | GCST90498532 | 0.57 |
| 4810 | Tea with sugar liking | GCST90094857 | 0.57 |
| 4811 | Mackerel liking | GCST90094796 | 0.57 |
| 4812 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122) | GCST90320685 | 0.57 |
| 4813 | Cholesterol_[M+H-H2O]1+ levels | GCST90060133 | 0.57 |
| 4814 | MEPE levels | GCST90469889 | 0.57 |
| 4815 | AGRP/NPY ratio | GCST90313203 | 0.57 |
| 4816 | Other diseases of blood and blood-forming organs, wide | FING00000999 | 0.57 |
| 4817 | Recent trouble relaxing | Anxiety | UKBB00000745 | 0.57 |
| 4818 | Phenylalanine levels | GCST90499228 | 0.57 |
| 4819 | PLAUR/PRSS8 ratio | GCST90315675 | 0.57 |
| 4820 | C1QTNF1/COL18A1 ratio | GCST90313551 | 0.57 |
| 4821 | CCL17/CD69 ratio | GCST90313684 | 0.57 |
| 4822 | DTI TBSS L2 Splenium of corpus callosum | GCST90384480 | 0.57 |
| 4823 | CYB5R2 levels | GCST90468937 | 0.57 |
| 4824 | ARHGAP1/SPARC ratio | GCST90313344 | 0.57 |
| 4825 | rfMRI connectivity (ICA100 edge 1066) | GCST90005919 | 0.57 |
| 4826 | Irritable mood | GCST006941 | 0.57 |
| 4827 | aseg lh number HolesBeforeFixing | GCST90002630 | 0.57 |
| 4828 | SERPINF2 levels | GCST90470599 | 0.57 |
| 4829 | IDP dMRI TBSS MD Genu of corpus callosum | GCST90004029 | 0.57 |
| 4830 | F3/GFRA1 ratio | GCST90314741 | 0.57 |
| 4831 | DTI autoptx L3 slf r tract | GCST90385215 | 0.57 |
| 4832 | IDP T1 FAST ROIs L cerebellum X | GCST90002587 | 0.57 |
| 4833 | ADD1 levels | GCST90468233 | 0.57 |
| 4834 | Other contact dermatitis | FING00000990 | 0.56 |
| 4835 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T341 | ECGU000341 | 0.56 |
| 4836 | Cholesteryl Esters in Large HDL | GCST90497751 | 0.56 |
| 4837 | Treatment/medication code - seretide 50 evohaler | Medications | UKBB00000858 | 0.56 |
| 4838 | Interpolated Year when operation took place | Operations | UKBB00000372 | 0.56 |
| 4839 | High density lipoprotein cholesterol levels | GCST90239651 | 0.56 |
| 4840 | Phosphatidylcholine-O_38:5_[M+H]1+/Phosphatidylcholine-P_38:4_[M+H]1+ levels | GCST90060375 | 0.56 |
| 4841 | T1 FreeSurfer a2009s lh S postcentral volume | GCST90384882 | 0.56 |
| 4842 | Omega-6 fatty acids to total fatty acids percentage | GCST90502121 | 0.56 |
| 4843 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T144 | ECGA000144 | 0.56 |
| 4844 | aseg lh volume choroid-plexus | GCST90002629 | 0.56 |
| 4845 | Cholesteryl esters to total lipids in large VLDL percentage (UKB data field 23591) | GCST90269688 | 0.56 |
| 4846 | Disorders of sclera, cornea, iris and ciliary body | FING00000458 | 0.56 |
| 4847 | IDP dMRI TBSS FA Superior fronto-occipital fasciculus R | GCST90003919 | 0.56 |
| 4848 | Migraine without aura | FING00000821 | 0.56 |
| 4849 | Spread type: Any oil based spread vs never use spread (UKB data field 1428) | GCST90132949 | 0.56 |
| 4850 | BPIFB1 levels | GCST90468462 | 0.56 |
| 4851 | Monounsaturated fatty acid levels | GCST90499090 | 0.56 |
| 4852 | NID1 levels | GCST90470047 | 0.56 |
| 4853 | MAP3K5 levels | GCST90469854 | 0.56 |
| 4854 | Volume of right anterior amygdaloid area | GCST90475000 | 0.56 |
| 4855 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T291 | ECGA000291 | 0.56 |
| 4856 | Triglyceride levels | GCST90239663 | 0.56 |
| 4857 | Cancer within the respiratory system (PheCode 165) | GCST90475571 | 0.56 |
| 4858 | Sphingomyelin_34:1_[M+H]1+ levels | GCST90060239 | 0.56 |
| 4859 | BACH1/DIABLO ratio | GCST90313437 | 0.56 |
| 4860 | ALPP/MSLN ratio | GCST90313250 | 0.56 |
| 4861 | ATP5IF1/METAP1D ratio | GCST90313391 | 0.56 |
| 4862 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T158 | ECGA000158 | 0.56 |
| 4863 | PLIN3/VSIR ratio | GCST90315679 | 0.56 |
| 4864 | Sequelae of cerebrovascular disease | FING00001294 | 0.56 |
| 4865 | Vegetable intake (standard GWA) | GCST90267306 | 0.56 |
| 4866 | CSF1 levels | GCST90468881 | 0.56 |
| 4867 | Urine methylsuccinoylcarnitine levels in chronic kidney disease | GCST90265509 | 0.56 |
| 4868 | Neutrophil count | GCST90025977 | 0.56 |
| 4869 | FGR/LBR ratio | GCST90314814 | 0.56 |
| 4870 | LGALS3 levels | GCST90012009 | 0.56 |
| 4871 | KRT5 levels | GCST90469718 | 0.55 |
| 4872 | CDH17 levels | GCST90468669 | 0.55 |
| 4873 | PON2 levels | GCST90470286 | 0.55 |
| 4874 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502049 | 0.55 |
| 4875 | ICD10 N97.0: Female infertility associated with anovulation | GCST90454223 | 0.55 |
| 4876 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T259 | ECGA000259 | 0.55 |
| 4877 | Phosphatidylcholine (34:5) levels | GCST90024286 | 0.55 |
| 4878 | Reaction time | GCST003499 | 0.55 |
| 4879 | Cholesteryl esters in very large VLDL | GCST90500556 | 0.55 |
| 4880 | CAG-177 sp003538135 abundance in stool | GCST90032260 | 0.55 |
| 4881 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T350 | ECGU000350 | 0.55 |
| 4882 | Trunk fat mass | Impedance measures | UKBB00000863 | 0.55 |
| 4883 | AXIN1 levels | GCST90468405 | 0.55 |
| 4884 | CCL17/CCL22 ratio | GCST90313682 | 0.55 |
| 4885 | NUCB2/TXNDC5 ratio | GCST90315578 | 0.55 |
| 4886 | IL1R1 levels | GCST90425563 | 0.55 |
| 4887 | Recent feelings of foreboding | Anxiety | UKBB00000738 | 0.55 |
| 4888 | Phospholipids in medium HDL | GCST90498635 | 0.55 |
| 4889 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T265 | ECGA000265 | 0.55 |
| 4890 | Left molecular layer hippocampal volume (body) | GCST90267953 | 0.55 |
| 4891 | Free cholesterol in medium VLDL | GCST90498960 | 0.55 |
| 4892 | Triglycerides to Total Lipids in Small VLDL percentage | GCST90499922 | 0.55 |
| 4893 | Cough on most days | Medical information | UKBB00000153 | 0.55 |
| 4894 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T109 | ECGU000109 | 0.55 |
| 4895 | Cholesterol in Large HDL | GCST90497709 | 0.55 |
| 4896 | IGF1R levels | GCST90469524 | 0.55 |
| 4897 | FKBP1B/PRDX5 ratio | GCST90314833 | 0.55 |
| 4898 | CX3CL1/DSG2 ratio | GCST90314323 | 0.55 |
| 4899 | XG levels | GCST90471082 | 0.55 |
| 4900 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90093042 | 0.55 |
| 4901 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T307 | ECGU000307 | 0.55 |
| 4902 | DTI TBSS L2 Sagittal stratum L | GCST90384507 | 0.55 |
| 4903 | CXCL11/VTA1 ratio | GCST90314337 | 0.55 |
| 4904 | Cataracts | GCST90475382 | 0.55 |
| 4905 | Phospholipid levels in chylomicrons and extremely large VLDL | GCST90501031 | 0.54 |
| 4906 | Peptic ulcer disease | GCST90270926 | 0.54 |
| 4907 | DTI TBSS L2 External capsule L | GCST90384509 | 0.54 |
| 4908 | Total lipids in small VLDL | GCST90499849 | 0.54 |
| 4909 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T299 | ECGA000299 | 0.54 |
| 4910 | Lung cancer in never smokers | GCST90277434 | 0.54 |
| 4911 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T216 | ECGU000216 | 0.54 |
| 4912 | CLEC1B/LGALS8 ratio | GCST90314096 | 0.54 |
| 4913 | HNMT levels | GCST90469468 | 0.54 |
| 4914 | High myopia | GCST009962 | 0.54 |
| 4915 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90093040 | 0.54 |
| 4916 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T203 | ECGU000203 | 0.54 |
| 4917 | COMP/ICAM1 ratio | GCST90314189 | 0.54 |
| 4918 | TGFB1 levels | GCST90470843 | 0.54 |
| 4919 | MSRA levels | GCST90469951 | 0.54 |
| 4920 | Allergic rhinitis | FING00000071 | 0.54 |
| 4921 | IGSF8 levels | GCST90469540 | 0.54 |
| 4922 | AHCY levels | GCST90468259 | 0.54 |
| 4923 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T161 | ECGA000161 | 0.54 |
| 4924 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T441 | ECGA000441 | 0.54 |
| 4925 | mean corpuscular hemoglobin (MCH, mean, inv-norm transformed) | GCST90475444 | 0.54 |
| 4926 | Free cholesterol in medium LDL | GCST90498767 | 0.54 |
| 4927 | AXIN1/DOK2 ratio | GCST90313406 | 0.54 |
| 4928 | CDH5/PEAR1 ratio | GCST90313959 | 0.54 |
| 4929 | TIMP3/ZBTB16 ratio | GCST90315921 | 0.54 |
| 4930 | Wet age-related macular degeneration | FING00001448 | 0.54 |
| 4931 | Lipoma of skin and subcutaneous tissue (PheCode 214.1) | GCST90475619 | 0.54 |
| 4932 | Cholesteryl Esters in Small LDL | GCST90499578 | 0.54 |
| 4933 | Deoxycholic acid glucuronide metabolite level | GCST90616229 | 0.54 |
| 4934 | Degree of unsaturation | GCST90502230 | 0.54 |
| 4935 | Pizza liking | GCST90094810 | 0.54 |
| 4936 | Cholesterol to total lipids ratio in small LDL | GCST90092957 | 0.54 |
| 4937 | VTA1 levels | GCST90471058 | 0.54 |
| 4938 | aparc-a2009s lh volume S-circular-insula-sup | GCST90002973 | 0.54 |
| 4939 | triglyceride (minimum, inv-norm transformed) | GCST90476437 | 0.54 |
| 4940 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T495 | ECGU000495 | 0.54 |
| 4941 | BANK1 levels | GCST90468421 | 0.54 |
| 4942 | aparc-a2009s lh area S-orbital-med-olfact | GCST90003359 | 0.53 |
| 4943 | Turnip liking | GCST90094861 | 0.53 |
| 4944 | Diseases of esophagus | digestive | UKBB00000184 | 0.53 |
| 4945 | Cholesteryl Esters in IDL | GCST90497523 | 0.53 |
| 4946 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T322 | ECGA000322 | 0.53 |
| 4947 | IRAK1/NFATC1 ratio | GCST90315194 | 0.53 |
| 4948 | SERPINA12 levels | GCST90470581 | 0.53 |
| 4949 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T478 | ECGU000478 | 0.53 |
| 4950 | Beta-hydroxyisovaleroylcarnitine levels | GCST90199802 | 0.53 |
| 4951 | ADGRE5/ITGB2 ratio | GCST90313180 | 0.53 |
| 4952 | Maximum workload during fitness test | ECG during exercise | UKBB00000432 | 0.53 |
| 4953 | MPHOSPH8 levels | GCST90469934 | 0.53 |
| 4954 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T380 | ECGA000380 | 0.53 |
| 4955 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T263 | ECGU000263 | 0.53 |
| 4956 | PDLIM7/TBC1D23 ratio | GCST90315640 | 0.53 |
| 4957 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T329 | ECGA000329 | 0.53 |
| 4958 | MDK levels | GCST90469877 | 0.53 |
| 4959 | Takes medication for blood clot/ pulmonary embolism/ deep vein thrombosis (DVT)? | GCST90475210 | 0.53 |
| 4960 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T129 | ECGA000129 | 0.53 |
| 4961 | Phospholipids to total lipids in small HDL percentage (UKB data field 23644) | GCST90269741 | 0.53 |
| 4962 | Coxarthrosis | FING00000362 | 0.53 |
| 4963 | Phosphatidylcholine (40:8) levels | GCST90024299 | 0.53 |
| 4964 | FSTL3 levels | GCST90425765 | 0.53 |
| 4965 | Physical activity (Relative amplitude) | GCST90061432 | 0.53 |
| 4966 | PDCD6 levels | GCST90470183 | 0.53 |
| 4967 | Operation code - hip replacement/revision | Operations | UKBB00000558 | 0.53 |
| 4968 | ITGB1/VASN ratio | GCST90315232 | 0.53 |
| 4969 | Other venous embolism and thrombosis (PheCode 452) | GCST90476007 | 0.53 |
| 4970 | IMPA1/TBCC ratio | GCST90315175 | 0.53 |
| 4971 | NCAN levels | GCST90470005 | 0.53 |
| 4972 | SMOC2 levels | GCST90060059 | 0.52 |
| 4973 | aparc-a2009s rh thickness G-temporal-middle | GCST90003714 | 0.52 |
| 4974 | STX16 levels | GCST90470769 | 0.52 |
| 4975 | HippSubfield rh volume subiculum-head | GCST90002693 | 0.52 |
| 4976 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T474 | ECGU000474 | 0.52 |
| 4977 | OGN levels | GCST90470119 | 0.52 |
| 4978 | ITGB1BP2 levels | GCST90012058 | 0.52 |
| 4979 | ABHD14B/SPARC ratio | GCST90313146 | 0.52 |
| 4980 | OSMR levels | GCST90470132 | 0.52 |
| 4981 | Triglycerides to total lipids in very large VLDL percentage (UKB data field 23588) | GCST90269685 | 0.52 |
| 4982 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T208 | ECGA000208 | 0.52 |
| 4983 | RASSF2 levels | GCST90470431 | 0.52 |
| 4984 | ATRN levels | GCST90468400 | 0.52 |
| 4985 | IL12A_IL12B/LAG3 ratio | GCST90315147 | 0.52 |
| 4986 | IDP T1 FAST ROIs R lingual gyrus | GCST90002522 | 0.52 |
| 4987 | Depression | Mental distress | UKBB00000165 | 0.52 |
| 4988 | CRTAM/FCRL6 ratio | GCST90314274 | 0.52 |
| 4989 | F13B levels | GCST90469167 | 0.52 |
| 4990 | FAM171B levels | GCST90090339 | 0.52 |
| 4991 | CLEC1B/DAB2 ratio | GCST90314086 | 0.52 |
| 4992 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T434 | ECGU000434 | 0.52 |
| 4993 | Monounsaturated fatty acids to total fatty acids percentage | GCST90499109 | 0.52 |
| 4994 | Saturated fatty acids levels | GCST90502194 | 0.52 |
| 4995 | Triglycerides in IDL | GCST90497671 | 0.52 |
| 4996 | Triglycerides to total lipids in small HDL percentage (UKB data field 23648) | GCST90269745 | 0.52 |
| 4997 | Omega-3 fatty acid levels | GCST90502062 | 0.52 |
| 4998 | CD40LG/MPIG6B ratio | GCST90313825 | 0.52 |
| 4999 | IDP T1 FAST ROIs R ventral striatum | GCST90002560 | 0.52 |
| 5000 | N-acetylphenylalanine levels | GCST90200677 | 0.52 |